Valeritas gets C Mark OK for disposable insulin device; Carticept gets FDA clearance for Navigator;

> New Jersey-based Valeritas has received European C Mark approval for its V-Go disposable insulin delivery device. Release

> Carticept Medical, based in Georgia, has received FDA clearance to market its Navigator computer controlled drug delivery system. Article

> Micell Technologies has finished enrolling patients in its DESSOLVE II CE Mark clinical study of the MiStent Drug-Eluting Coronary Stent System. The Durham, NC company has enrolled 183 patients across 26 centers throughout Europe and New Zealand. Release

> Drug delivery patent of the week: Pharmaceutical compositions and methods for delivering nucleic acids into cells. Patent

Suggested Articles

The new digital Abilify is a breakthrough for Proteus Digital Health and its patient-tracking products, but not so much for Abilify's maker, Otsuka.

Adamis Pharmaceuticals' EpiPen contender Symjepi, which was rejected last year before the EpiPen havoc, won approval from the FDA.

Researchers in the U.K. have developed a technique to better predict results in liver cancer when drug-laden polymer beads are used to deliver medicines.